14 pending office actions • 10 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18245879 | Untitled | SunnyBay BioTech, Inc. | BERHANE, SELAM | 1675 | Non-Final OA | |
| 18253677 | Untitled | BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD. | HOPKINS, SAMANTHA LAKE | 1641 | Non-Final OA | |
| 18995701 | WIND POWERED GENERATION SYSTEM | Studman Innovations Pty Ltd | FLORES, JUAN G | 3745 | Non-Final OA | Jan 16, 2025 |
| 18486941 | Methods of Treating Human X-Linked Retinoschisis Using Gene Therapy | Teamedon International, Inc. | NGUYEN, QUANG | 1631 | Non-Final OA | Oct 13, 2023 |
| 18260214 | ANTI-PD-1/CD47 BISPECIFIC ANTIBODY AND USE THEREOF | Abvision, Inc. | LEE, YIE CHIA | 1642 | Non-Final OA | Jun 30, 2023 |
| 18337000 | DNA METHELATION MOLECULAR MARKERS FOR IDENTIFYING BENIGNITY OR MALIGNANCY OF LUNG NODULE AND APPLICATIONS OF THE SAME | AnchorDx Medical Co., Ltd. | POHNERT, STEVEN C | 1683 | Non-Final OA | Jun 17, 2023 |
| 18253695 | ANTI-CD276 ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF | BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD. | JOHANSEN, PETER N. | 1644 | Non-Final OA | May 19, 2023 |
| 18253703 | ANTI-CD73 ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF | BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD. | GODDARD, LAURA B | 1642 | Non-Final OA | May 19, 2023 |
| 18161655 | Methods of Treating Human X-Linked Retinoschisis Using Gene Therapy | Teamedon International, Inc. | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Non-Final OA | Jan 30, 2023 |
| 17995855 | ENDOGENOUS RETROVIRUSES FOR THE DETECTION, DIAGNOSIS, AND PROGNOSIS OF CANCER | SunnyBay BioTech, Inc. | SCHLOOP, ALLISON ELIZABETH | 1683 | Non-Final OA | Oct 08, 2022 |
| 17827604 | Highly effective blood-glucose-lowering protein drug | Xintrum Pharmaceuticals, Ltd. | BRADLEY, CHRISTINA | 1654 | Final Rejection | May 27, 2022 |
| 17628614 | ANTI-CD47/ANTI-LAG-3 BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF | Nanjing Genscript Biotech Co., Ltd. | SUNSHINE, HANNAH LOUISE | 1647 | Final Rejection | Jan 20, 2022 |
| 17624505 | ANTI-CD47/ANTI-CTLA-4 BISPECIFIC ANTIBODY AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Nanjing Genscript Biotech Co., Ltd. | CUNNINGCHEN, KATHLEEN MARY | 1646 | Non-Final OA | Jan 03, 2022 |
| 17617156 | MONOCLONAL ANTIBODY-CYTOKINE FUSION PROTEIN DIMER AND APPLICATION THEREOF | Nanjing Genscript Biotech Co., Ltd. | LU, CHENG | 1642 | Final Rejection | Dec 07, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial